BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19018137)

  • 1. Lipoprotein-associated phospholipase A2 activity and risk of recurrent stroke.
    Elkind MS; Tai W; Coates K; Paik MC; Sacco RL
    Cerebrovasc Dis; 2009; 27(1):42-50. PubMed ID: 19018137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke.
    Elkind MS; Tai W; Coates K; Paik MC; Sacco RL
    Arch Intern Med; 2006 Oct; 166(19):2073-80. PubMed ID: 17060536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of lipoprotein-associated phospholipase A
    Han L; Zhong C; Bu X; Xu T; Wang A; Peng Y; Xu T; Wang J; Peng H; Li Q; Ju Z; Geng D; Zhang Y; He J;
    Atherosclerosis; 2017 Nov; 266():1-7. PubMed ID: 28934604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein-associated phospholipase A2, hormone use, and the risk of ischemic stroke in postmenopausal women.
    Wassertheil-Smoller S; Kooperberg C; McGinn AP; Kaplan RC; Hsia J; Hendrix SL; Manson JE; Berger JS; Kuller LH; Allison MA; Baird AE
    Hypertension; 2008 Apr; 51(4):1115-22. PubMed ID: 18259035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein-associated phospholipase A2 and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities (ARIC) study.
    Nambi V; Hoogeveen RC; Chambless L; Hu Y; Bang H; Coresh J; Ni H; Boerwinkle E; Mosley T; Sharrett R; Folsom AR; Ballantyne CM
    Stroke; 2009 Feb; 40(2):376-81. PubMed ID: 19095974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein-associated phospholipase A(2) activity is associated with large-artery atherosclerotic etiology and recurrent stroke in TIA patients.
    Delgado P; Chacón P; Penalba A; Pelegri D; García-Berrocoso T; Giralt D; Santamarina E; Ribó M; Maisterra O; Alvarez-Sabín J; Rosell A; Montaner J
    Cerebrovasc Dis; 2012; 33(2):150-8. PubMed ID: 22178747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women.
    Blake GJ; Dada N; Fox JC; Manson JE; Ridker PM
    J Am Coll Cardiol; 2001 Nov; 38(5):1302-6. PubMed ID: 11691499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein-associated phospholipase A(2) and risk of congestive heart failure in older adults: the Cardiovascular Health Study.
    Suzuki T; Solomon C; Jenny NS; Tracy R; Nelson JJ; Psaty BM; Furberg C; Cushman M
    Circ Heart Fail; 2009 Sep; 2(5):429-36. PubMed ID: 19808373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of Lipoprotein-Associated Phospholipase A
    Tibuakuu M; Kianoush S; DeFilippis AP; McEvoy JW; Zhao D; Guallar E; Ballantyne CM; Hoogeveen RC; Blaha MJ; Michos ED
    Am J Cardiol; 2018 May; 121(9):1056-1064. PubMed ID: 29525060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-sensitivity C-reactive protein and lipoprotein-associated phospholipase A2 stability before and after stroke and myocardial infarction.
    Elkind MS; Leon V; Moon YP; Paik MC; Sacco RL
    Stroke; 2009 Oct; 40(10):3233-7. PubMed ID: 19644070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein-associated phospholipase A2 is associated with atherosclerotic stroke risk: the Northern Manhattan Study.
    Katan M; Moon YP; Paik MC; Wolfert RL; Sacco RL; Elkind MS
    PLoS One; 2014; 9(1):e83393. PubMed ID: 24416164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
    Robins SJ; Collins D; Nelson JJ; Bloomfield HE; Asztalos BF
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1172-8. PubMed ID: 18356553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Lp-PLA2-A and early recurrence of vascular events after TIA and minor stroke.
    Lin J; Zheng H; Cucchiara BL; Li J; Zhao X; Liang X; Wang C; Li H; Mullen MT; Johnston SC; Wang Y; Wang Y;
    Neurology; 2015 Nov; 85(18):1585-91. PubMed ID: 26311748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
    Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Chambless LE; Myerson M; Wu KK; Sharrett AR; Boerwinkle E
    Arch Intern Med; 2005 Nov; 165(21):2479-84. PubMed ID: 16314544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 and YKL-40 predicted recurrent stroke after ischemic stroke or TIA: analysis of 6 inflammation biomarkers in a prospective cohort study.
    Li J; Lin J; Pan Y; Wang M; Meng X; Li H; Wang Y; Zhao X; Qin H; Liu L; Wang Y;
    J Neuroinflammation; 2022 Jun; 19(1):131. PubMed ID: 35761288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of carotid plaque Lp-PLA(2) with macrophages and Chlamydia pneumoniae infection among patients at risk for stroke.
    Atik B; Johnston SC; Dean D
    PLoS One; 2010 Jun; 5(6):e11026. PubMed ID: 20543948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein-associated phospholipase A2 testing usefulness among patients with symptomatic intracranial atherosclerotic disease.
    Massot A; Pelegri D; Penalba A; Arenillas J; Boada C; Giralt D; Ribó M; Molina CA; Rosell A; Alvarez-Sabín J; Chacón P; Rovira A; Delgado P; Montaner J
    Atherosclerosis; 2011 Sep; 218(1):181-7. PubMed ID: 21620406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study.
    Oei HH; van der Meer IM; Hofman A; Koudstaal PJ; Stijnen T; Breteler MM; Witteman JC
    Circulation; 2005 Feb; 111(5):570-5. PubMed ID: 15699277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein-associated phospholipase A2 and C-reactive protein for risk-stratification of patients with TIA.
    Cucchiara BL; Messe SR; Sansing L; MacKenzie L; Taylor RA; Pacelli J; Shah Q; Kasner SE
    Stroke; 2009 Jul; 40(7):2332-6. PubMed ID: 19461040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Link between lipoprotein-associated phospholipase A2 gene expression of peripheral-blood mononuclear cells and prognostic outcome after acute ischemic stroke.
    Tsai TH; Chen YL; Lin HS; Liu CF; Chang HW; Lu CH; Chang WN; Chen SF; Wu CJ; Leu S; Ko SF; Yip HK
    J Atheroscler Thromb; 2012; 19(6):523-31. PubMed ID: 22447189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.